BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16373691)

  • 41. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
    Vuckovic S; Abdul Wahid FS; Rice A; Kato M; Khalil D; Rodwell R; Hart DN
    Exp Hematol; 2008 Nov; 36(11):1496-506. PubMed ID: 18715688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
    Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
    Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
    Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematopoietic capacity of adult human skeletal muscle is negligible.
    Allan DS; Jay KE; Bhatia M
    Bone Marrow Transplant; 2005 Apr; 35(7):663-6. PubMed ID: 15711572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient assay for evaluating human thrombopoiesis using NOD/SCID mice transplanted with cord blood CD34+ cells.
    Suzuki K; Hiramatsu H; Fukushima-Shintani M; Heike T; Nakahata T
    Eur J Haematol; 2007 Feb; 78(2):123-30. PubMed ID: 17087740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic treatment with mono-phenyl-tri-(N-methyl-4-pyridyl)-porphyrin for pathogen inactivation in cord blood stem cell products.
    Trannoy LL; van Hensbergen Y; Lagerberg JW; Brand A
    Transfusion; 2008 Dec; 48(12):2629-37. PubMed ID: 18764827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.
    van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE
    Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concentration of mast-cell progenitors in bone marrow, spleen, and blood of mice determined by limiting dilution analysis.
    Sonoda T; Ohno T; Kitamura Y
    J Cell Physiol; 1982 Jul; 112(1):136-40. PubMed ID: 7107713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in F36VMpl-based in vivo selection among large animal models.
    Richard RE; De Claro RA; Yan J; Chien S; Von Recum H; Morris J; Kiem HP; Dalgarno DC; Heimfeld S; Clackson T; Andrews R; Blau CA
    Mol Ther; 2004 Oct; 10(4):730-40. PubMed ID: 15451457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
    Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
    Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transgene expression after stable transfer of a mammalian artificial chromosome into human hematopoietic cells.
    Vanderbyl SL; Sullenbarger B; White N; Perez CF; MacDonald GN; Stodola T; Bunnell BA; Ledebur HC; Lasky LC
    Exp Hematol; 2005 Dec; 33(12):1470-6. PubMed ID: 16338489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
    Beer PA; Knapp DJ; Kannan N; Miller PH; Babovic S; Bulaeva E; Aghaeepour N; Rabu G; Rostamirad S; Shih K; Wei L; Eaves CJ
    Stem Cell Reports; 2014 Nov; 3(5):841-57. PubMed ID: 25418728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The number of functional hematopoietic clones in mice with bone marrow recovery depends upon the dose of transplanted cells].
    Drize NI; Todriia TV; Chertkov IL
    Biull Eksp Biol Med; 1997 Jul; 124(7):86-9. PubMed ID: 9303741
    [No Abstract]   [Full Text] [Related]  

  • 54. Bone marrow toxicity in mice treated with indium-114m-labelled blood cells.
    Hoyes KP; Wadeson PJ; Murby B; Sharma HL; Cowan RA; Lord BI
    J Exp Clin Cancer Res; 2001 Dec; 20(4):505-10. PubMed ID: 11876543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluctuations of BFUe and CFUe cycling after erytrhoid perturbations: correlation with variations of pool size.
    Peschle C; Cillo C; Migliaccio G; Lettieri F
    Exp Hematol; 1980 Jan; 8(1):96-102. PubMed ID: 7409040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Kinetics of hematopoietic clones in reconstituted mice].
    Drize NI; Sadovnikova EIu; Olovnikova NI; Belkina EV; Nikolaeva TL; Chertkov IL
    Biull Eksp Biol Med; 1997 Feb; 123(2):180-3. PubMed ID: 9280491
    [No Abstract]   [Full Text] [Related]  

  • 57. [Functional reserves of the pool of committed bone marrow hematopoietic precursors in AKR/JY mice during preleukemic period].
    Khlusov IA; Kosnyreva LA; Kusmartsev SA; Dygaĭ AM; Gol'dberg ED
    Biull Eksp Biol Med; 1999 Nov; 128(11):578-81. PubMed ID: 10640252
    [No Abstract]   [Full Text] [Related]  

  • 58. Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system.
    Dal Negro G; Vandin L; Bonato M; Sciuscio D
    Toxicol In Vitro; 2006 Aug; 20(5):743-9. PubMed ID: 16324821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythroid progenitors in human fetal liver.
    Kimura N; Yamano Y; Niho Y; Yanase T
    Nihon Ketsueki Gakkai Zasshi; 1984 Sep; 47(6):1235-41. PubMed ID: 6516705
    [No Abstract]   [Full Text] [Related]  

  • 60. The relative spatial distribution of erythroid progenitor cells (BFUe and CFUe) in the normal mouse femur.
    Frassoni F; Testa NG; Lord BI
    Cell Tissue Kinet; 1982 Jul; 15(4):447-55. PubMed ID: 7105134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.